Literature DB >> 24710715

Analysis of structure-Caco-2 permeability relationships using a property landscape approach.

Yareli Rojas-Aguirre1, José L Medina-Franco.   

Abstract

Understanding the relationship between the chemical structure of bioactive compounds and Caco-2 permeability is of major importance in modern drug discovery. The purpose of this work was to characterize systematically the Caco-2 permeability landscape of a benchmark dataset of 100 molecules using a novel approach based on the emerging concept of property landscape modeling. Pairwise comparisons of the Caco-2 permeability and chemical structures were calculated for all possible combinations in the dataset. To compare the chemical structures, two distinct manners to represent the molecules were employed, namely, continuous properties previously used to derive QSPR models and molecular fingerprints with different designs. We introduce the concept of "permeability cliffs" discussing cases of compounds with high molecular similarity but large permeability difference. All permeability cliffs were regarded as shallow cliffs, since no extreme difference in Caco-2 permeability (less than two log units) was identified in the dataset. A clear dependence of Caco-2 permeability landscape with molecular representation was observed. The current approach can be further extended to model other ADME relevant landscapes.

Mesh:

Year:  2014        PMID: 24710715     DOI: 10.1007/s11030-014-9514-x

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  36 in total

Review 1.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

Review 2.  Toward in silico structure-based ADMET prediction in drug discovery.

Authors:  Gautier Moroy; Virginie Y Martiny; Philippe Vayer; Bruno O Villoutreix; Maria A Miteva
Journal:  Drug Discov Today       Date:  2011-10-29       Impact factor: 7.851

3.  Activity landscape representations for structure-activity relationship analysis.

Authors:  Anne Mai Wassermann; Mathias Wawer; Jürgen Bajorath
Journal:  J Med Chem       Date:  2010-09-16       Impact factor: 7.446

4.  Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors.

Authors:  E C Y Chan; W L Tan; P C Ho; L J Fang
Journal:  J Chromatogr A       Date:  2005-04-29       Impact factor: 4.759

5.  On outliers and activity cliffs--why QSAR often disappoints.

Authors:  Gerald M Maggiora
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

6.  Evaluation of cocktail approach to standardise Caco-2 permeability experiments.

Authors:  Maija Koljonen; Kati S Hakala; Tuula Ahtola-Sätilä; Leena Laitinen; Risto Kostiainen; Tapio Kotiaho; Ann Marie Kaukonen; Jouni Hirvonen
Journal:  Eur J Pharm Biopharm       Date:  2006-06-30       Impact factor: 5.571

7.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.

Authors:  G Camenisch; J Alsenz; H van de Waterbeemd; G Folkers
Journal:  Eur J Pharm Sci       Date:  1998-10       Impact factor: 4.384

8.  Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model.

Authors:  V Pade; S Stavchansky
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

9.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

10.  Drug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents.

Authors:  L Hovgaard; H Brøndsted; A Buur; H Bundgaard
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

View more
  2 in total

1.  Activity landscape analysis of novel 5α-reductase inhibitors.

Authors:  J Jesús Naveja; Francisco Cortés-Benítez; Eugene Bratoeff; José L Medina-Franco
Journal:  Mol Divers       Date:  2016-02-01       Impact factor: 2.943

2.  A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer.

Authors:  Yi Li; Kexin Wang; Yupeng Chen; Jieqi Cai; Xuemei Qin; Aiping Lu; Daogang Guan; Genggeng Qin; Weiguo Chen
Journal:  Front Pharmacol       Date:  2021-11-16       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.